Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Do quality of life and work productivity change in early axial spondyloarthritis and non-axial spondyloarthritis patients after 2 years?

Da Silva, Ana Bento ; Ramiro, Sofia ; Boel, Anne ; Van Lunteren, Miranda ; Marques, Mary Lucy ; Van De Sande, Marleen ; Fongen, Camilla ; Exarchou, Sofia LU ; Ramonda, Roberta and Van Der Heijde, Désirée , et al. (2025) In Rheumatology 64(4). p.1826-1834
Abstract

Objective: The objective of this study was to compare health-related quality of life (HRQoL) and work productivity in axial SpA (axSpA) and non-axSpA patients with chronic back pain of <2 years. Methods: Baseline and 2-year data for patients included in the SPondyloArthritis Caught Early cohort were analysed. HRQoL was assessed by the physical (PCS) and mental component summary (MCS) scores of the 36-Item Short-Form Health Survey, and presenteeism, absenteeism, work productivity loss (WPL) and activity impairment (AI) by the Work Productivity and Activity Impairment questionnaire. Linear or zero-inflated negative binomial regression was conducted to compare 2-year outcomes between groups (axSpA and non-axSpA), adjusting for the... (More)

Objective: The objective of this study was to compare health-related quality of life (HRQoL) and work productivity in axial SpA (axSpA) and non-axSpA patients with chronic back pain of <2 years. Methods: Baseline and 2-year data for patients included in the SPondyloArthritis Caught Early cohort were analysed. HRQoL was assessed by the physical (PCS) and mental component summary (MCS) scores of the 36-Item Short-Form Health Survey, and presenteeism, absenteeism, work productivity loss (WPL) and activity impairment (AI) by the Work Productivity and Activity Impairment questionnaire. Linear or zero-inflated negative binomial regression was conducted to compare 2-year outcomes between groups (axSpA and non-axSpA), adjusting for the baseline value, sex, age and use of NSAIDs. Results: There were 265 axSpA and 108 non-axSpA patients: males 52% vs 26%, mean age 29 vs 31 years, respectively. At baseline, non-axSpA patients showed worse PCS (mean 28.6 axSpA vs 26.6 non-axSpA), presenteeism (31.1% vs 37.3%), absenteeism (8.2% vs 10.3%), WPL (34.7% vs 44.1%) and AI (39.6% vs 48.5%). MCS was not impaired in either group. After 2 years, PCS, presenteeism, WPL and AI significantly improved in both groups; absenteeism only improved in axSpA. In multivariable analysis, axSpA (vs non-axSpA) was associated with 22% less WPL [incidence rate ratio (95% CI): 0.78 (0.62; 0.98)] and 18% less AI [0.82 (0.69; 0.97)]. Conclusion: HRQoL and work productivity are more impaired in non-axSpA (vs axSpA) at baseline and also after 2 years. Although most outcomes improve in both groups, axSpA is associated with larger reductions in WPL and AI.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
axial spondyloarthritis, chronic back pain, quality of life, work productivity
in
Rheumatology
volume
64
issue
4
pages
9 pages
publisher
Oxford University Press
external identifiers
  • pmid:38937277
  • scopus:105001697543
ISSN
1462-0324
DOI
10.1093/rheumatology/keae346
language
English
LU publication?
yes
additional info
Publisher Copyright: © 2024 The Author(s).
id
37532ec8-bc06-46bb-ac5b-cb008227c2c2
date added to LUP
2025-12-05 14:00:38
date last changed
2025-12-19 22:57:27
@article{37532ec8-bc06-46bb-ac5b-cb008227c2c2,
  abstract     = {{<p>Objective: The objective of this study was to compare health-related quality of life (HRQoL) and work productivity in axial SpA (axSpA) and non-axSpA patients with chronic back pain of &lt;2 years. Methods: Baseline and 2-year data for patients included in the SPondyloArthritis Caught Early cohort were analysed. HRQoL was assessed by the physical (PCS) and mental component summary (MCS) scores of the 36-Item Short-Form Health Survey, and presenteeism, absenteeism, work productivity loss (WPL) and activity impairment (AI) by the Work Productivity and Activity Impairment questionnaire. Linear or zero-inflated negative binomial regression was conducted to compare 2-year outcomes between groups (axSpA and non-axSpA), adjusting for the baseline value, sex, age and use of NSAIDs. Results: There were 265 axSpA and 108 non-axSpA patients: males 52% vs 26%, mean age 29 vs 31 years, respectively. At baseline, non-axSpA patients showed worse PCS (mean 28.6 axSpA vs 26.6 non-axSpA), presenteeism (31.1% vs 37.3%), absenteeism (8.2% vs 10.3%), WPL (34.7% vs 44.1%) and AI (39.6% vs 48.5%). MCS was not impaired in either group. After 2 years, PCS, presenteeism, WPL and AI significantly improved in both groups; absenteeism only improved in axSpA. In multivariable analysis, axSpA (vs non-axSpA) was associated with 22% less WPL [incidence rate ratio (95% CI): 0.78 (0.62; 0.98)] and 18% less AI [0.82 (0.69; 0.97)]. Conclusion: HRQoL and work productivity are more impaired in non-axSpA (vs axSpA) at baseline and also after 2 years. Although most outcomes improve in both groups, axSpA is associated with larger reductions in WPL and AI.</p>}},
  author       = {{Da Silva, Ana Bento and Ramiro, Sofia and Boel, Anne and Van Lunteren, Miranda and Marques, Mary Lucy and Van De Sande, Marleen and Fongen, Camilla and Exarchou, Sofia and Ramonda, Roberta and Van Der Heijde, Désirée and Van Gaalen, Floris}},
  issn         = {{1462-0324}},
  keywords     = {{axial spondyloarthritis; chronic back pain; quality of life; work productivity}},
  language     = {{eng}},
  month        = {{04}},
  number       = {{4}},
  pages        = {{1826--1834}},
  publisher    = {{Oxford University Press}},
  series       = {{Rheumatology}},
  title        = {{Do quality of life and work productivity change in early axial spondyloarthritis and non-axial spondyloarthritis patients after 2 years?}},
  url          = {{http://dx.doi.org/10.1093/rheumatology/keae346}},
  doi          = {{10.1093/rheumatology/keae346}},
  volume       = {{64}},
  year         = {{2025}},
}